Pesquisas alternativas:
nail compr » nail compared (Expandir a Pesquisa), nail company (Expandir a Pesquisa), nail complex (Expandir a Pesquisa)
chimp can » chip can (Expandir a Pesquisa), chirp can (Expandir a Pesquisa), camp can (Expandir a Pesquisa)
l chimp » _ chimp (Expandir a Pesquisa), l chip (Expandir a Pesquisa), _ jchimp (Expandir a Pesquisa)
cll new » cell new (Expandir a Pesquisa), all new (Expandir a Pesquisa), ball new (Expandir a Pesquisa)
tran » trad (Expandir a Pesquisa), trap (Expandir a Pesquisa)
ngoc » ngo (Expandir a Pesquisa)
nail compr » nail compared (Expandir a Pesquisa), nail company (Expandir a Pesquisa), nail complex (Expandir a Pesquisa)
chimp can » chip can (Expandir a Pesquisa), chirp can (Expandir a Pesquisa), camp can (Expandir a Pesquisa)
l chimp » _ chimp (Expandir a Pesquisa), l chip (Expandir a Pesquisa), _ jchimp (Expandir a Pesquisa)
cll new » cell new (Expandir a Pesquisa), all new (Expandir a Pesquisa), ball new (Expandir a Pesquisa)
tran » trad (Expandir a Pesquisa), trap (Expandir a Pesquisa)
ngoc » ngo (Expandir a Pesquisa)
1
Por Reyes, Maria Ines, Nash, Tara E., Dallas, Mary M., Ascencio-Ibáñez, J. Trinidad, Hanley-Bowdoin, Linda
Publicado em 2013
“... rates, allowing them to adapt rapidly to new hosts and environments. Thus, an effective resistance...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
“...FDA approval of new therapies in 2011 has greatly expanded the treatment options for metastatic...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Slager, Susan L., Rabe, Kari G., Achenbach, Sara J., Vachon, Celine M., Goldin, Lynn R., Strom, Sara S., Lanasa, Mark C., Spector, Logan G., Rassenti, Laura Z., Leis, Jose F., Camp, Nicola J., Glenn, Martha, Kay, Neil E., Cunningham, Julie M., Hanson, Curtis A., Marti, Gerald E., Weinberg, J. Brice, Morrison, Vicki A., Link, Brian K., Call, Timothy G., Caporaso, Neil E., Cerhan, James R.
Publicado em 2011
“... specific to these familial CLL cases. Our top hits from these analyses were evaluated in an additional...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por M. Fere, L.H. Liu, C. Gobinet, A. Beljebbar, V. Untereiner, J.-F. Angiboust, M. Manfait, G. Gheldof, H. Jacquemin, S. Walbrecq, E. Cornet, X. Troussard, B. Chatelain, J. Angelo, M. Chollat, J. Klossa, O. Piot
Publicado em 2016-06-01
“...) is based on the microscopic analysis of cell morphology from patient blood smear. However, new photonic...”Publicado em 2016-06-01
Obter o texto integral
Artigo
5
Por Raveche, Elizabeth S., Salerno, Erica, Scaglione, Brian J., Manohar, Vijaya, Abbasi, Fatima, Lin, Yi-Chu, Fredrickson, Torgny, Landgraf, Pablo, Ramachandra, Sumant, Huppi, Konrad, Toro, Jorge R., Zenger, Vincent E., Metcalf, Robert A., Marti, Gerald E.
Publicado em 2007
“...New Zealand black (NZB) mice with autoimmune and B lymphoproliferative disease (B-LPD) are a model...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... by this antibody appears to be distinct from known B cell markers, and is put forward as a new B cell marker...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Sylvester, Steven P., Soreng, Robert J., Bravo-Pedraza, William J., Cuta-Alarcon, Lia E., Giraldo-Cañas, Diego, Aguilar-Cano, Jose, Peterson, Paul M.
Publicado no PhytoKeys (2019)
“... differs from all other species of Calamagrostis s.l. by the presence of strongly curled, readily deciduous...”Publicado no PhytoKeys (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Steven P. Sylvester, Robert J. Soreng, William J. Bravo-Pedraza, Lia E. Cuta-Alarcon, Diego Giraldo-Cañas, Jose Aguilar-Cano, Paul M. Peterson
Publicado em 2019-05-01
“.... Calamagrostis crispifolius differs from all other species of Calamagrostis s.l. by the presence of strongly...”Publicado em 2019-05-01
Obter o texto integral
Artigo
9
Por Gupta, Rashmi, Li, Wentian, Yan, Xiao J, Barrientos, Jacqueline, Kolitz, Jonathan E., Allen, Steven L., Rai, Kanti, Chiorazzi, Nicholas, Mongini, Patricia K. A.
Publicado no J Immunol (2019)
“...-CLL growth could illuminate new therapeutic targets. Using CpG DNA-primed human B-CLL clones...”Publicado no J Immunol (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por KVARNSTRÖM, M, SIDOROVA, E, NILSSON, J, EKERFELT, C, VRETHEM, M, SÖDERBERG, O, JOHANSSON, M, ROSÉN, A, ERNERUDH, J
Publicado em 2002
“..., can be found not only in different autoimmune diseases, such as peripheral neuropathy (PN), but also...”Publicado em 2002
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Rawstron, A C, Fazi, C, Agathangelidis, A, Villamor, N, Letestu, R, Nomdedeu, J, Palacio, C, Stehlikova, O, Kreuzer, K-A, Liptrot, S, O'Brien, D, de Tute, R M, Marinov, I, Hauwel, M, Spacek, M, Dobber, J, Kater, A P, Gambell, P, Soosapilla, A, Lozanski, G, Brachtl, G, Lin, K, Boysen, J, Hanson, C, Jorgensen, J L, Stetler-Stevenson, M, Yuan, C, Broome, H E, Rassenti, L, Craig, F, Delgado, J, Moreno, C, Bosch, F, Egle, A, Doubek, M, Pospisilova, S, Mulligan, S, Westerman, D, Sanders, C M, Emerson, R, Robins, H S, Kirsch, I, Shanafelt, T, Pettitt, A, Kipps, T J, Wierda, W G, Cymbalista, F, Hallek, M, Hillmen, P, Montserrat, E, Ghia, P
Publicado no Leukemia (2016)
“... is an independent predictor of outcome. Given the increasing number of new agents being explored for CLL therapy...”Publicado no Leukemia (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“... from the obstacle boundaries, subsequently curled, and spawned new "daughter" wavelets. We identified...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Sarwary, A. M. E., Stegeman, D. F., Selen, L. P. J., Medendorp, W. P.
Publicado no J Neurophysiol (2015)
“..., serving to access the correct internal model whenever necessary and keeping new models apart from previous...”Publicado no J Neurophysiol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Kim, S Y, Theunissen, J-W, Balibalos, J, Liao-Chan, S, Babcock, M C, Wong, T, Cairns, B, Gonzalez, D, van der Horst, E H, Perez, M, Levashova, Z, Chinn, L, D‘Alessio, J A, Flory, M, Bermudez, A, Jackson, D Y, Ha, E, Monteon, J, Bruhns, M F, Chen, G, Migone, T-S
Publicado no Blood Cancer J (2015)
“...Although several new therapeutic approaches have improved outcomes in the treatment of hematologic...”Publicado no Blood Cancer J (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Yeomans, Alison, Lemm, Elizabeth, Wilmore, Sarah, Cavell, Breeze E., Valle-Argos, Beatriz, Krysov, Sergey, Hidalgo, Marina Sanchez, Leonard, Elodie, Willis, Anne E., Forconi, Francesco, Stevenson, Freda K., Steele, Andrew J., Coldwell, Mark J., Packham, Graham
Publicado no Oncotarget (2016)
“... B cells derived from patients with chronic lymphocytic leukaemia (CLL). CLL cells were stimulated...”Publicado no Oncotarget (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Capron, C, Jondeau, K, Casetti, L, Jalbert, V, Costa, C, Verhoyen, E, Massé, J M, Coppo, P, Béné, M C, Bourdoncle, P, Cramer-Bordé, E, Dusanter-Fourt, I
Publicado no Cell Death Dis (2014)
“...-positive B lymphocytes. The clinical course of CLL is highly variable, ranging from a long-lasting indolent...”Publicado no Cell Death Dis (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Malcikova, J, Stano-Kozubik, K, Tichy, B, Kantorova, B, Pavlova, S, Tom, N, Radova, L, Smardova, J, Pardy, F, Doubek, M, Brychtova, Y, Mraz, M, Plevova, K, Diviskova, E, Oltova, A, Mayer, J, Pospisilova, S, Trbusek, M
Publicado no Leukemia (2015)
“... to drive the selection of new TP53 mutations in CLL. Using ultra-deep next-generation sequencing (NGS), we...”Publicado no Leukemia (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Mahoney, Emilia, Lucas, David M., Gupta, Sneha V., Wagner, Amy J., Herman, Sarah E. M., Smith, Lisa L., Yeh, Yuh-Ying, Andritsos, Leslie, Jones, Jeffrey A., Flynn, Joseph M., Blum, Kristie A., Zhang, Xiaoli, Lehman, Amy, Kong, Hui, Gurcan, Metin, Grever, Michael R., Johnson, Amy J., Byrd, John C.
Publicado em 2012
“... and ER stress were documented in tumor cells from CLL patients receiving flavopiridol. Thus, CLL cells...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
“...Three new diterpene alkaloids – the hypotaurocyamines, (−)-agelasidines E and F (5–6...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“... small molecule drugs suffer from dose-limiting toxicity and undesirable side effects. The need for new...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo